Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?
- PMID: 16648497
- DOI: 10.1200/JCO.2006.05.6788
Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?
Comment on
-
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.J Clin Oncol. 2006 May 1;24(13):2044-51. doi: 10.1200/JCO.2005.03.3332. J Clin Oncol. 2006. PMID: 16648504 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical